← SynDRA
3-AMINOBENZAMIDE
SynDRA canonical compound SYN0003352 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | PARP1 |
|---|
| Mechanism of action | PARP inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- PARP inhibitor
- PARP1 INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ACHE
- MMP1
- MC4R
- MC3R
- MAPK3
- MAPK14
- MAPK1
- MAOA
- LMNA
- LCK
- KDM4E
- KCNH2
- HTR6
- HTR2C
- HTR2B
- HTR2A
- HSD17B10
- HRH2
- HRH1
- HPGD
- HMGCR
- HDAC6
- FYN
- MC5R
- MMP9
- ADORA1
- NPY1R
- TBXAS1
- TACR2
- TACR1
- SLCO1B3
- SLCO1B1
- SLC6A4
- SLC6A3
- SLC6A2
- SIGMAR1
- PTPRC
- PTGS2
- PTGS1
- PTAFR
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Drug classes
- Neuroprotective Agents
- Poly(ADP-ribose) Polymerase Inhibitors
- Radiation-Sensitizing Agents
Cross-references
Synonyms
- m-Aminobenzamide
- Benzamide, 3-amino-
- 3-amino benzamide
- Benzamide, m-amino-
- meta-aminobenzamide
- 3-ABA
- 3-Aminobenzimide
- aniline-3-carboxamide
- 3-aminobenzoic acid amide
- UNII-8J365YF1YH
- CCRIS 3925
- EINECS 222-586-9
- NSC 36962
- BRN 2802373
- PARP Inhibitor I, 3-ABA
- 3-H2NC6H4CONH2
- CHEMBL81977
- 3-AB
- 8J365YF1YH
- CHEBI:64042
- GSCPDZHWVNUUFI-UHFFFAOYSA-N
- MFCD00007989
- 3-Aminobenzamide, 98%
- SR-01000075657
- HSDB 7581
- 3-azanylbenzamide
- m-amino benzamide
- 4pml
- 3-Aminobenzaminde
- BRD-K08703257
- 3-amino-benzamide
- RefChem:92958
- DTXCID50111413
- 3AB
- 3-carboxamidoaniline
- PARP-IN-1
- ZERENEX E/1009157
Look up 3-AMINOBENZAMIDE in the interactive SynDRA portal →